GGrantIndex
← Leaderboards

Charles G Glabe

University Of California Irvine

$19,961,839
Attributed
$26,164,623
Total exposure
19
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.9M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,164,623 · 19

By mechanism

RF1$12,306,707 · 4
R01$5,086,212 · 5
U24$4,533,350 · 1
P01$2,620,395 · 3
R56$698,846 · 1
P50$457,128 · 1

Top collaborators

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Antibodies

Research focus

AntibodiesAmyloidAlzheimer&AposPathogenesisBrainS DiseaseMolecular ConformationMonoclonal AntibodiesPathologyPeptidesPlayStructureAmyloid FibrilsIn VitroTransgenic MicePreventNeuronsCellsBaseResourcesMonomerSamplingDepositionEpitopes

Grant awards (49)

Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD$1,089,279
U24 · FY2025 · AG · contact PI
Cell-type-specific and spatial proteogenomics analysis of aberrant RNA splicing and misfolded proteins in Alzheimer's related tauopathies$773,816
R01 · FY2025 · AG
Temporal, Spatial and Cellular Dynamics of Amyloid Plaque Deposition$734,137
R01 · FY2025 · AG · contact PI
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD$1,089,279
U24 · FY2024 · AG · contact PI
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD$1,089,558
U24 · FY2023 · AG · contact PI
Temporal, Spatial and Cellular Dynamics of Amyloid Plaque Deposition$2,261,484
RF1 · FY2022 · AG · contact PI
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD$1,265,234
U24 · FY2022 · AG · contact PI
Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics$390,417
RF1 · FY2019 · AG · contact PI
Endogenous human antibodies in aging and Alzheimer's disease and the immune response to amyloid$3,508,837
RF1 · FY2018 · AG · contact PI
Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics$3,245,609
RF1 · FY2018 · AG · contact PI
Age-related metabolic alterations in amyloid processing in Alzheimer's disease$2,900,360
RF1 · FY2018 · AG
INTRACELLULAR AMYLOID ACCUMULATION, INNATE IMMUNITY AND PATHOGENESIS$284,075
P01 · FY2018 · AG · contact PI
Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics$698,846
R56 · FY2017 · AG · contact PI
INTRACELLULAR AMYLOID ACCUMULATION, INNATE IMMUNITY AND PATHOGENESIS$284,076
P01 · FY2017 · AG · contact PI
INTRACELLULAR AMYLOID ACCUMULATION, INNATE IMMUNITY AND PATHOGENESIS$284,075
P01 · FY2016 · AG · contact PI
INTRACELLULAR AMYLOID ACCUMULATION, INNATE IMMUNITY AND PATHOGENESIS$275,553
P01 · FY2015 · AG · contact PI
Novel nuclear and intracellular pathology in early AD$186,725
R21 · FY2015 · AG · contact PI
INTRACELLULAR AMYLOID ACCUMULATION, INNATE IMMUNITY AND PATHOGENESIS$284,076
P01 · FY2014 · AG · contact PI
Structure and conformational diversity of amyloid oligomers$280,828
R01 · FY2014 · AG · contact PI
Novel nuclear and intracellular pathology in early AD$244,541
R21 · FY2014 · AG · contact PI
Structure and conformational diversity of amyloid oligomers$267,779
R01 · FY2013 · AG · contact PI
Structure and conformational diversity of amyloid oligomers$285,589
R01 · FY2012 · AG · contact PI
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS$240,915
P01 · FY2012 · AG · contact PI
Structure and conformational diversity of amyloid oligomers$287,541
R01 · FY2011 · AG · contact PI
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS$241,338
P01 · FY2011 · AG · contact PI
Structure and conformational diversity of amyloid oligomers$279,199
R01 · FY2010 · AG · contact PI
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS$243,774
P01 · FY2010 · AG · contact PI
SITE-SPECIFIC STUDIES PROVIDE STRUCTURAL INFORMATION ON AMYLOID BETA OLIGOMERS$18,018
P41 · FY2010 · RR · contact PI
STRUCTURE & CONFORMATIONAL DIVERSITY OF AMYLOID AGGREGATES BY FCS$4,731
P41 · FY2010 · RR · contact PI
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS$238,870
P01 · FY2009 · AG · contact PI
STRUCTURE & CONFORMATIONAL DIVERSITY OF AMYLOID AGGREGATES BY FCS$7,970
P41 · FY2009 · RR · contact PI
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS$243,643
P01 · FY2008 · AG · contact PI
Structure of Amyloid A Beta & Fibril Assembly Dynamics$257,281
R01 · FY2007 · NS · contact PI
Structure of Amyloid A Beta & Fibril Assembly Dynamics$264,965
R01 · FY2006 · NS · contact PI
Structure of Amyloid A Beta &Fibril Assembly Dynamics$271,341
R01 · FY2005 · NS
Structure of Amyloid A Beta &Fibril Assembly Dynamics$270,610
R01 · FY2004 · NS
Structure of Amyloid A Beta &Fibril Assembly Dynamics$283,119
R01 · FY2003 · NS
DEGRADATION OF THE TRANSMEMBRANE DOMAIN OF APP$216,790
R01 · FY2003 · NS
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$228,564
P50 · FY2002 · AG
DEGRADATION OF THE TRANSMEMBRANE DOMAIN OF APP$210,476
R01 · FY2002 · NS
Biological &Biochemical Properties of AB Isoforms$0
P01 · FY2002 · AG
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$228,564
P50 · FY2001 · AG
DEGRADATION OF THE TRANSMEMBRANE DOMAIN OF APP$204,346
R01 · FY2001 · NS
Biological &Biochemical Properties of AB Isoforms$0
P01 · FY2001 · AG
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$0
P50 · FY2001 · AG
DEGRADATION OF THE TRANSMEMBRANE DOMAIN OF APP$198,395
R01 · FY2000 · NS
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$0
P50 · FY2000 · AG
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$0
P50 · FY2000 · AG
Amyloid Accumulation Mechanisms/Pathogenesis in AD Brain$0
P50 · FY2000 · AG